Project data
Funding entity: European Commission
Call: IMI2-2020-20-02 – Innovations to accelerate vaccine development vaccine development and manufacture
Coordinator: EUROPEAN VACCINE INITIATIVE – EEIG (Germany)
UNISI Principal Investigator: Donata Medaglini
Department: Medical biotechnologies
Start date: 1 September 2021 – End date: 28 February 2027
Description
Vaccines protect millions from death, illness and disability. The COVID-19 pandemic has highlighted many challenges hampering vaccine development. The EU funded Inno4Vac project will address scientific bottlenecks in vaccine development. Inno4Vac proposes to develop predictive biological and mathematical models of vaccine performance and manufacturing. Artificial intelligence combined with big data and computational modelling will be used to build an open-access and cloud-based platform for in silico vaccine efficacy assessment and development. Controlled human infection models and cell-based human in vitro 3D models will be developed to enable early evaluation of vaccine efficacy and prediction of immune protection. Finally, an open source in silico simulation platform will guide the production of vaccine candidates and associated stability testing.
Source: Cordis
This project has received funding from the European Union’s Horizon 2020 programme under GA No 101007799